Leo Bleicher

1.1k total citations
15 papers, 762 citations indexed

About

Leo Bleicher is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Leo Bleicher has authored 15 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Leo Bleicher's work include Nicotinic Acetylcholine Receptors Study (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Leo Bleicher is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Leo Bleicher collaborates with scholars based in United States, United Kingdom and Canada. Leo Bleicher's co-authors include Nicholas D. P. Cosford, Mark A. Varney, Pat Prodanovich, Mark E. Williams, Rebecca L. Cole, Guibao Gu, Sandra Lechner, Ian A. McDonald, Aida Sacaan and J. S. MCCALLUM and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Comparative Neurology and Analytical Biochemistry.

In The Last Decade

Leo Bleicher

15 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo Bleicher United States 12 393 302 156 101 93 15 762
Ole V. Mortensen United States 16 470 1.2× 540 1.8× 40 0.3× 63 0.6× 52 0.6× 37 944
Andréia C. K. Fontana United States 19 575 1.5× 716 2.4× 32 0.2× 140 1.4× 118 1.3× 36 1.2k
John Guastella United States 18 1.1k 2.8× 1.1k 3.7× 252 1.6× 144 1.4× 152 1.6× 21 2.1k
Dean F. Revell United Kingdom 13 489 1.2× 479 1.6× 75 0.5× 85 0.8× 128 1.4× 16 960
Jean-Pierre Changeux France 9 1.3k 3.2× 490 1.6× 72 0.5× 104 1.0× 226 2.4× 9 1.4k
Sreekanth Puttachary United States 14 217 0.6× 367 1.2× 14 0.1× 91 0.9× 63 0.7× 17 738
Zi-Wei Chen United States 16 592 1.5× 431 1.4× 56 0.4× 27 0.3× 38 0.4× 25 917
Peter Grundt United States 25 1.0k 2.5× 1.2k 3.9× 317 2.0× 101 1.0× 76 0.8× 49 1.8k
E Weber United States 25 1.6k 4.0× 1.8k 5.9× 101 0.6× 329 3.3× 68 0.7× 43 2.4k
Alison J. Smith United States 16 515 1.3× 758 2.5× 247 1.6× 109 1.1× 58 0.6× 30 1.3k

Countries citing papers authored by Leo Bleicher

Since Specialization
Citations

This map shows the geographic impact of Leo Bleicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Bleicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Bleicher more than expected).

Fields of papers citing papers by Leo Bleicher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Bleicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Bleicher. The network helps show where Leo Bleicher may publish in the future.

Co-authorship network of co-authors of Leo Bleicher

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Bleicher. A scholar is included among the top collaborators of Leo Bleicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Bleicher. Leo Bleicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bleicher, Leo, Moises Hassan, Jayaraman Chandrasekhar, et al.. (2022). Enhanced utility of AI/ML methods during lead optimization by inclusion of 3D ligand information. SHILAP Revista de lepidopterología. 2. 7 indexed citations
2.
Targum, Steven D., Pamela Wedel, Jill O. Robinson, et al.. (2013). A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive Disorder. Journal of Psychiatric Research. 47(7). 944–954. 26 indexed citations
3.
Paveley, Ross A., Nuha R. Mansour, Irene Hallyburton, et al.. (2012). Whole Organism High-Content Screening by Label-Free, Image-Based Bayesian Classification for Parasitic Diseases. PLoS neglected tropical diseases. 6(7). e1762–e1762. 73 indexed citations
4.
Fava, Maurizio, Steven D. Targum, Andrew A. Nierenberg, et al.. (2012). An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery. Journal of Psychiatric Research. 46(12). 1553–1563. 56 indexed citations
5.
Cole, Rebecca L., Sandra Lechner, Mark E. Williams, et al.. (2005). Differential distribution of voltage‐gated calcium channel alpha‐2 delta (α2δ) subunit mRNA‐containing cells in the rat central nervous system and the dorsal root ganglia. The Journal of Comparative Neurology. 491(3). 246–269. 176 indexed citations
6.
Chua, Peter, Johnny Nagasawa, Leo Bleicher, et al.. (2005). Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(20). 4589–4593. 11 indexed citations
7.
Hodder, Peter, James Inglese, Bradley P. Feuston, et al.. (2003). Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system. Analytical Biochemistry. 313(2). 246–254. 35 indexed citations
8.
Cosford, Nicholas D. P., Leo Bleicher, Jean‐Michel Vernier, et al.. (2000). Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharmaceutica Acta Helvetiae. 74(2-3). 125–130. 20 indexed citations
9.
Varney, Mark A., Nicholas D. P. Cosford, Christine Jachec, et al.. (1999). SIB-1757 and SIB-1893: Selective, Noncompetitive Antagonists of Metabotropic Glutamate Receptor Type 5. Journal of Pharmacology and Experimental Therapeutics. 290(1). 170–181. 151 indexed citations
10.
Bleicher, Leo & Nicholas D. P. Cosford. (1999). A Novel Method for the Racemization of 5-Bromonicotine. The Journal of Organic Chemistry. 64(14). 5299–5300. 12 indexed citations
11.
Vernier, Jean‐Michel, Nicholas D. P. Cosford, Leo Bleicher, et al.. (1999). 4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]- phenol Hydrochloride (SIB-1553A):  A Novel Cognitive Enhancer with Selectivity for Neuronal Nicotinic Acetylcholine Receptors. Journal of Medicinal Chemistry. 42(10). 1684–1686. 36 indexed citations
14.
Sacaan, Aida, Richard T. Reid, Emily M. Santori, et al.. (1997). Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist. Journal of Pharmacology and Experimental Therapeutics. 280(1). 373–383. 39 indexed citations
15.
Bleicher, Leo & Nicholas D. P. Cosford. (1995). Aryl- and Heteroaryl-Alkyne Coupling Reactions Catalyzed by Palladium on Carbon and CuI in an Aqueous Medium. Synlett. 1995(11). 1115–1116. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026